DJIA 16,493.37 -69.93 -0.42%
NASDAQ 4,352.64 -17.13 -0.39%
S&P 500 1,925.15 -5.52 -0.29%
market minute promo

Dendreon Corp (NASDAQ: DNDN)

2.07 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

DNDN $2.07 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.08
Previous Close $2.07
Daily Range $2.02 - $2.11
52-Week Range $1.81 - $5.38
Market Cap $331.1M
P/E Ratio -1.21
Dividend (Yield) $0.00 (0.0%)
Volume 1,561,693
Average Daily Volume 1,921,942
Current FY EPS -$0.79





Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website:

News & Commentary

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

3 Convincing Reasons To Buy Dendreon

Why You Should Buy Dendreon's Drop

August 29th Options Now Available For Dendreon

Stocks To Watch Today: NQ Mobile, CBS, Seadrill...

Morning Market Movers

Benzinga's Top #PreMarket Gainers

New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May

What Does Dendreon Need To Succeed?

Dendreon (DNDN) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape

Long Or Short: Cancer Cures

See More DNDN News...

DNDN's Top Competitors

DNDN $2.07 (0.00%)
Current stock: DNDN
AMGN $125.55 (-1.44%)
Current stock: AMGN
GILD $91.50 (-0.05%)
Current stock: GILD
BIIB $329.83 (-1.36%)
Current stock: BIIB